Psychiatry & Neurology, Clinical Neurophysiology · New York, NY
NPI
1831151281
Since 2006
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
223 E 34th St
New York, NY, 10016
Phone (646) 558-0800
Groups this clinician bills Medicare through
Medicare paid, 2024
$134K
664 services
Medicare patients, 2024
413
Average age 73
Drug cost, 2024
$1.5M
714 prescriptions
Company payments, 2025
$213K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alcibiades J Rodriguez was code 99214 (office e&m - established), 140 times for 111 patients. In total Alcibiades J Rodriguez billed 664 services in 25 codes, and Medicare paid $134K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 140 | 111 | $101.74 | $14K |
| 95810 Sleep Study | Office | 72 | 70 | $541.46 | $39K |
| 99205 Office E&M - New | Office | 68 | 68 | $186.93 | $13K |
| 95720 Neurologic | Facility | 61 | 47 | $179.65 | $11K |
| 94660 Treatment - Miscellaneous | Office | 60 | 57 | $53.18 | $3,191 |
| 99215 Office E&M - Established | Office | 47 | 47 | $153.15 | $7,198 |
| 95800 Sleep Study | Office | 33 | 31 | $30.89 | $1,019 |
| 95811 Sleep Study | Office | 29 | 29 | $556.26 | $16K |
| 95812 Neurologic | Office | 17 | 17 | $40.09 | $682 |
| 95718 Neurologic | Facility | 17 | 17 | $116.71 | $1,984 |
| 95816 Neurologic | Office | 17 | 17 | $45.26 | $769 |
| 95721 Neurologic | Office | 13 | 13 | $180.32 | $2,344 |
| 95716 Neurologic | Office | 12 | 12 | $1,032.60 | $12K |
| 95700 Neurologic | Office | 12 | 12 | $213.32 | $2,560 |
| 95720 Neurologic | Office | 12 | 12 | $183.87 | $2,206 |
By year: 2022 $198K for 1,031 services; 2023 $155K for 819 services; 2024 $134K for 664 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alcibiades J Rodriguez prescribed most often to Medicare patients was Zaleplon, with 102 prescriptions and refills. In total Alcibiades J Rodriguez wrote 714 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zaleplon Generic | 102 | 102 | 24 | $2,205 |
| Zolpidem Tartrate Generic | 94 | 96 | 17 | $583 |
| Gabapentin Generic | 42 | 57 | 12 | $501 |
| Doxepin Hcl Generic | 38 | 45 | Under 11 | $1,284 |
| Eszopiclone Generic | 37 | 37 | Under 11 | $428 |
| Clonazepam Generic | 34 | 34 | Under 11 | $207 |
| Xywav Sodium,calcium,mag,pot Oxybate | 31 | 31 | Under 11 | $619K |
| Sunosi Solriamfetol Hcl | 30 | 38 | Under 11 | $32K |
| Trazodone Hcl Generic | 27 | 43 | Under 11 | $289 |
| Quetiapine Fumarate Generic | 27 | 37 | Under 11 | $812 |
| Alprazolam Generic | 26 | 26 | Under 11 | $126 |
| Lunesta Eszopiclone | 24 | 24 | Under 11 | $21K |
| Wakix Pitolisant Hcl | 20 | 20 | Under 11 | $311K |
| Lorazepam Generic | 14 | 14 | Under 11 | $155 |
| Adderall Xr Dextroamphetamine/Amphetamine | 14 | 14 | Under 11 | $7,357 |
Brand drugs: 188 claims; generic drugs: 526 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alcibiades J Rodriguez $213K ($213K in general payments such as food, travel and fees) from 13 companies. The largest payer was Lilly USA, LLC with $91K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 116 | $91K |
| Axsome Therapeutics, Inc. AXSM | 51 | $62K |
| Jazz Pharmaceuticals Inc. JAZZ | 47 | $38K |
| Avadel CNS Pharmaceuticals, LLC | 20 | $17K |
| Harmony Biosciences LLC HRMY | 25 | $1,479 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $1,316 |
| LivaNova USA, Inc. LIVN | 1 | $800 |
| Neurelis, Inc. | 21 | $458 |
| SK Life Science, Inc. | 4 | $109 |
| Inspire Medical Systems, Inc. INSP | 4 | $96.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.